Scholar Rock Holding Corp
apitegromab
spinal muscular atrophy (SMA)
Resolved
7days ago
Approval decision · Jun 30, 2026
What's at stake
A final FDA approval decision on apitegromab for spinal muscular atrophy (SMA) is expected Jun 30, 2026.
Primary source
· SEC 8-K
verified 15h ago
“European launch expected in H2 2026, starting with Germany”